Tc99m-MAA Bronchial Artery Injection During Bronchial Embolization for Pulmonary Mass Induced Hemoptysis for Dosimetry Planning

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

June 1, 2024

Study Completion Date

July 1, 2024

Conditions
Lung Cancer
Interventions
BIOLOGICAL

Tc99m-MAA

Tc99m-MAA is a particle that is used to assess blood flow distribution and has a similar size to the particles that are utilized for arterial delivery of radiation therapy, also called radioembolization. Tc99m-MAA is currently used to estimate radiation dosimetry prior to arterial radiotherapy administration for liver malignancies.

Trial Locations (1)

02114

Massachusetts General Hospital Cancer Center, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

BTG International Inc.

OTHER

lead

Massachusetts General Hospital

OTHER